UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 524

Sortiert nach

Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti‐tumour effect in vivo

Clinical and experimental immunology, 2013-06, Vol.172 (3), p.500-506

2013

Volltextzugriff (PDF)

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

Gut, 2003-09, Vol.52 (9), p.1347-1354

2003

Volltextzugriff (PDF)

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats

Hepatology (Baltimore, Md.), 2001-10, Vol.34 (4), p.745-750

2001

Volltextzugriff (PDF)

Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse

Hepatology (Baltimore, Md.), 2002-10, Vol.36 (4), p.850-860

2002

Volltextzugriff (PDF)

Possible involvement of angiogenesis in chronic liver diseases: interaction among renin-angiotensin-aldosterone system, insulin resistance and oxidative stress

Current medicinal chemistry, 2012-04, Vol.19 (12), p.1889

2012

Volltextzugriff (PDF)

The Angiotensin-I-converting Enzyme Inhibitor Perindopril Suppresses Tumor Growth and Angiogenesis: Possible Role of the Vascular Endothelial Growth Factor

Clinical cancer research, 2001-04, Vol.7 (4), p.1073-1078

2001

Volltextzugriff (PDF)

Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice

Gut, 2005-12, Vol.54 (12), p.1768-1775

2005

Volltextzugriff (PDF)

Sulforaphane Inhibits Liver Cancer Cell Growth and Angiogenesis

Annals of Behavioural Science, 2018, Vol.4 (2)

2018

Volltextzugriff (PDF)

CERTAIN-1: efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S527-S527

2017

Volltextzugriff (PDF)

Antifibrotic Effects of Combined Treatment with Farnesoid X Receptor Agonist and Angiotensin-II Type1 Receptor Blocker on Hepatic Fibrogenesis in the Rat Model of Nonalcoholic Steatohepatitis

Journal of hepatology, 2016, Vol.64 (2), p.S686-S686

2016

Volltextzugriff (PDF)

Impact of the Combination of Dipeptidyl Peptidase IV Inhibitor and Angiotensin-II Type 1 Receptor Blocker on Hepatocarcinogenesis in a Rat Model of Nonalcoholic Steatohepatitis

Journal of hepatology, 2016, Vol.64 (2), p.S582-S582

2016

Volltextzugriff (PDF)

Impact of renin-angiotensin system in hepatocellular carcinoma

Current cancer drug targets, 2011-05, Vol.11 (4), p.431

2011

Volltextzugriff (PDF)

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

World journal of gastroenterology : WJG, 2017-12, Vol.23 (47), p.8355-8366

2017

Volltextzugriff (PDF)

Possible liver regeneration and anti-fibrogenic effect of NOTCH1 selective inhibitor in the diseased liver model

Journal of hepatology, 2018-04, Vol.68, p.S399

2018

Volltextzugriff (PDF)

FRI-086 - Possible liver regeneration and anti-fibrogenic effect of NOTCH1 selective inhibitor in the diseased liver model

Journal of hepatology, 2018-04, Vol.68, p.S399-S399

2018

Volltextzugriff (PDF)

Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells

International journal of oncology, 2002-06, Vol.20 (6), p.1227

2002

Volltextzugriff (PDF)

Is patient-reported outcome improved by nalfurafine hydrochloride in patients with primary biliary cholangitis and refractory pruritus? A post-marketing, single-arm, prospective study

Journal of gastroenterology, 2018-10, Vol.53 (10), p.1151-1158

2018

Volltextzugriff (PDF)

The Evolving Landscape of Liver Cirrhosis Management

1st ed. 2019., 2019

Volltextzugriff (PDF)

Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development

Hepatology research, 2006-10, Vol.36 (2), p.124-129

2006

Volltextzugriff (PDF)

The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model

Hepatology (Baltimore, Md.), 2001-04, Vol.33 (4), p.841-847

2001

Volltextzugriff (PDF)

SAT-526 - Moderate alcohol consumption protects against fatty liver in males

Journal of hepatology, 2018-04, Vol.68, p.S841-S841

2018

Volltextzugriff (PDF)

Particle-mediated gene transfer into murine livers using a newly developed gene gun

Gene therapy, 2000-07, Vol.7 (13), p.1132-1136

2000

Volltextzugriff (PDF)

Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies

Gut, 2004-08, Vol.53 (8), p.1167-1173

2004

Volltextzugriff (PDF)

Effect of nalfurafine hydrochloride for refractory pruritus in patients with primary biliary cholangitis: a multicenter, post-marketing, single-arm, prospective study

Journal of hepatology, 2018-04, Vol.68, p.S228

2018

Volltextzugriff (PDF)

THU-223 - Effect of nalfurafine hydrochloride for refractory pruritus in patients with primary biliary cholangitis: a multicenter, post-marketing, single-arm, prospective study

Journal of hepatology, 2018-04, Vol.68, p.S228-S228

2018

Volltextzugriff (PDF)

1 – 25 von 524

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(433)
Mit Volltextzugriff
(457)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(513)
Japanisch
(185)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti‐tumour effect in vivo

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats

Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse

Possible involvement of angiogenesis in chronic liver diseases: interaction among renin-angiotensin-aldosterone system, insulin resistance and oxidative stress

The Angiotensin-I-converting Enzyme Inhibitor Perindopril Suppresses Tumor Growth and Angiogenesis: Possible Role of the Vascular Endothelial Growth Factor

Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice

Sulforaphane Inhibits Liver Cancer Cell Growth and Angiogenesis

CERTAIN-1: efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

Antifibrotic Effects of Combined Treatment with Farnesoid X Receptor Agonist and Angiotensin-II Type1 Receptor Blocker on Hepatic Fibrogenesis in the Rat Model of Nonalcoholic Steatohepatitis

Impact of the Combination of Dipeptidyl Peptidase IV Inhibitor and Angiotensin-II Type 1 Receptor Blocker on Hepatocarcinogenesis in a Rat Model of Nonalcoholic Steatohepatitis

Impact of renin-angiotensin system in hepatocellular carcinoma

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

Possible liver regeneration and anti-fibrogenic effect of NOTCH1 selective inhibitor in the diseased liver model

FRI-086 - Possible liver regeneration and anti-fibrogenic effect of NOTCH1 selective inhibitor in the diseased liver model

Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells

Is patient-reported outcome improved by nalfurafine hydrochloride in patients with primary biliary cholangitis and refractory pruritus? A post-marketing, single-arm, prospective study

The Evolving Landscape of Liver Cirrhosis Management

Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development

The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model

SAT-526 - Moderate alcohol consumption protects against fatty liver in males

Particle-mediated gene transfer into murine livers using a newly developed gene gun

Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies

Effect of nalfurafine hydrochloride for refractory pruritus in patients with primary biliary cholangitis: a multicenter, post-marketing, single-arm, prospective study

THU-223 - Effect of nalfurafine hydrochloride for refractory pruritus in patients with primary biliary cholangitis: a multicenter, post-marketing, single-arm, prospective study

Suchergebnisse filtern